Isis Lipid-Lowering Drug Shows Benefit In Phase II For Familial Hypercholesterolemia
This article was originally published in The Pink Sheet Daily
Executive Summary
Isis 301012 shows treatment benefit as an add-on therapy to statins and other drugs.